The phosphatidylinositol 3-kinases (PI3K) inhibitor GS-1101 synergistically potentiates histone deacetylase inhibitor-induced proliferation inhibition and apoptosis through the inactivation of PI3K and extracellular signal-regulated kinase pathways.
about
The role of idelalisib in the treatment of relapsed and refractory chronic lymphocytic leukemiaIdelalisib for the treatment of chronic lymphocytic leukemiaTargeting neoplastic B cells and harnessing microenvironment: the "double face" of ibrutinib and idelalisibTherapeutic targeting of replicative immortalityMCL-1 and BCL-xL-dependent resistance to the BCL-2 inhibitor ABT-199 can be overcome by preventing PI3K/AKT/mTOR activation in lymphoid malignancies.Dual inhibition of histone deacetylases and phosphoinositide 3-kinase enhances therapeutic activity against B cell lymphoma.Targeting PI3-kinase (PI3K), AKT and mTOR axis in lymphoma.Anti-tumor activity of the combination of bendamustine with vorinostat in diffuse large B-cell lymphoma cells.Tris (dibenzylideneacetone) dipalladium: a small-molecule palladium complex is effective in inducing apoptosis in chronic lymphocytic leukemia B-cells.Panobinostat as Pan-deacetylase Inhibitor for the Treatment of Pancreatic Cancer: Recent Progress and Future Prospects.Idelalisib Impacts Cell Growth through Inhibiting Translation-Regulatory Mechanisms in Mantle Cell Lymphoma.The protective role of interleukin-11 against neutron radiation injury in mouse intestines via MEK/ERK and PI3K/Akt dependent pathways.
P2860
Q26751006-504B7529-C459-4A5F-9A6F-A5FCAFA702A5Q27015826-53E82273-F3D5-4694-B13D-4B9698BC08A4Q27025812-85150571-3B23-414B-BB47-D06F61296B74Q27027457-3745F4B8-3CB9-435D-848C-5958DDE74A7DQ33419789-DA47895C-F6EA-4EF0-A27A-A312F9B884D6Q37706739-CA455AC7-4625-4EB0-8A34-FE2AF87E35B2Q38237619-8385F633-7B82-424B-8AD6-49BBE73A72BBQ38862949-C14A1747-6856-462F-812A-CA0BEA6F7861Q41652556-45A74627-C92B-4A69-AF7E-823DC147F0A9Q51034578-26994C8F-7139-409E-A211-971875D4EA3BQ51682819-1CAFD433-0123-4816-96EF-13C4500F129FQ54382785-32EB1290-B2F1-4A06-9608-7C3BD3D9FCF2
P2860
The phosphatidylinositol 3-kinases (PI3K) inhibitor GS-1101 synergistically potentiates histone deacetylase inhibitor-induced proliferation inhibition and apoptosis through the inactivation of PI3K and extracellular signal-regulated kinase pathways.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 25 July 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The phosphatidylinositol 3-kin ...... nal-regulated kinase pathways.
@en
The phosphatidylinositol 3-kinases
@nl
type
label
The phosphatidylinositol 3-kin ...... nal-regulated kinase pathways.
@en
The phosphatidylinositol 3-kinases
@nl
prefLabel
The phosphatidylinositol 3-kin ...... nal-regulated kinase pathways.
@en
The phosphatidylinositol 3-kinases
@nl
P2093
P2860
P356
P1476
The phosphatidylinositol 3-kin ...... gnal-regulated kinase pathways
@en
P2093
Arishya Sharma
Brian J Lannutti
Brian T Hill
Eric D Hsi
Juraj Bodo
Xiaoxian Zhao
P2860
P356
10.1111/BJH.12498
P407
P577
2013-07-25T00:00:00Z